Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 3—March 2008


Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005

Andriyan Grinev*, Sylvester Daniel*, Susan L. Stramer†, Susan N. Rossmann‡, Sally Caglioti§, and Maria Rios*Comments to Author 
Author affiliations: *Food and Drug Administration, Bethesda, Maryland, USA; †American Red Cross, Gaithersburg, Maryland, USA; ‡Gulf Coast Regional Blood Center, Houston, Texas, USA; §Blood System Laboratories, Tempe, Arizona, USA;

Main Article

Table 3

Deduced amino acid substitutions in 8 completely sequenced West Nile virus isolates compared with isolate WN-NY99*

Isolate NS4B

2488 2549 2755 2788 2820 2826 2842 3056 3104 3132 3191 3238 3240
WN-NY99 Ser Lys Gly Asn Ser Glu Lys Pro Arg Arg Met Gln Pro Total
FDA/HU-02 5
ARC10–02 Gly 3
BSL5–03 Arg 6
BSL5–04 Ser Arg Lys Gln 8
GCTX1–05 Arg Ser Leu Arg Cys Ser Thr 16
GCTX2–05 Ser 3
BSL2–05 Gly Arg Gln 10
BSL13–05 Gly Arg Gln 8

*NS, nonstructural.

Main Article